Letters to the Editor

Phase II trial of dose-adjusted EPOCH in untreated systemic anaplastic large cell lymphoma

Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA
Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA
Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA
Biostatistics and Data Management Section, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA
Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA
Biostatistics and Data Management Section, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA
Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA
Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA
Vol. 101 No. 1 (2016): January, 2016 https://doi.org/10.3324/haematol.2015.131151